SG Americas Securities LLC Acquires 14,016 Shares of iShares Biotechnology ETF $IBB

SG Americas Securities LLC increased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 96.3% during the third quarter, HoldingsChannel.com reports. The fund owned 28,569 shares of the financial services provider’s stock after buying an additional 14,016 shares during the quarter. SG Americas Securities LLC’s holdings in iShares Biotechnology ETF were worth $4,125,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Citigroup Inc. increased its position in shares of iShares Biotechnology ETF by 27.0% during the 2nd quarter. Citigroup Inc. now owns 4,073,967 shares of the financial services provider’s stock valued at $515,398,000 after purchasing an additional 865,823 shares during the last quarter. JPMorgan Chase & Co. grew its position in iShares Biotechnology ETF by 74.2% during the second quarter. JPMorgan Chase & Co. now owns 833,196 shares of the financial services provider’s stock valued at $105,408,000 after buying an additional 355,000 shares during the period. Employees Retirement System of Texas purchased a new stake in iShares Biotechnology ETF during the second quarter worth about $25,049,000. Millennium Management LLC raised its position in iShares Biotechnology ETF by 140.8% in the first quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after acquiring an additional 143,893 shares during the period. Finally, Ashton Thomas Private Wealth LLC raised its position in iShares Biotechnology ETF by 769.9% in the second quarter. Ashton Thomas Private Wealth LLC now owns 63,691 shares of the financial services provider’s stock worth $8,058,000 after acquiring an additional 56,369 shares during the period. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $172.39 on Monday. The firm has a 50 day moving average price of $168.14 and a 200-day moving average price of $150.16. iShares Biotechnology ETF has a twelve month low of $107.43 and a twelve month high of $179.64.

iShares Biotechnology ETF Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were issued a dividend of $0.1831 per share. This represents a $0.73 annualized dividend and a yield of 0.4%. This is a positive change from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. The ex-dividend date of this dividend was Tuesday, December 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.